Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer

Carcinoembryonic antigen in monitoring of response to cetuximab plus FOLFIRI or FOLFOX-4 in patients with metastatic colorectal cancer

(2017) H.L. Tsai et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS

Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse

(2011) C-Y Lu et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer

(2011) Satoshi Matsusaka et al.   CANCER SCIENCE

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer after Complete Resection: An Updated Practice Guideline

(2011) D.J. Jonker et al.   CLINICAL ONCOLOGY

Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review

(2010) G Peach et al.   BRITISH JOURNAL OF CANCER

Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer

(2010) Nuh N. Rahbari et al.   GASTROENTEROLOGY

Perineural Invasion: Correlation With Aggressive Phenotype and Independent Prognostic Variable in Both Colon and Rectum Cancer

(2010) Eva M. Poeschl et al.   JOURNAL OF CLINICAL ONCOLOGY

Metastatic Colorectal Cancer: From Improved Survival to Potential Cure

(2010) David J. Gallagher et al.   ONCOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic

(2009) Alison L. Allan et al.   Journal of Oncology

Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection

(2008) Yih-Huei Uen et al.   ANNALS OF SURGICAL ONCOLOGY

Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer

(2008) Ralf Steinert   ARCHIVES OF SURGERY

Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives

(2008) Margherita Nannini et al.   CANCER TREATMENT REVIEWS